SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: stock bull who wrote (2256)3/31/1998 5:54:00 PM
From: Brian Moloney  Read Replies (3) of 3725
 
I have said from the beginning that I know nothing about the stock market, and so I am not going to add to the debate about whether this is good, bad, or indifferent.
I do have some good news. this week's Newsweek has a 2 column article with a headline and a picture on ultrafast CT and its advantages for screening for coronary disease. Imatron is not mentioned. There is a comparison to mammograms and an inference that the expense (with proper medical follow-up) could be well worth it. There is also a prediction that the low number of machines (40) and the spotty insurance coverage should be improving.
No info that all of us don't know but a welcome foray into the psyche of the American public. We need lots more of this.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News